Literature DB >> 33078310

MRI-visible perivascular spaces as an imaging biomarker in Fabry disease.

D Lyndon1, I Davagnanam2, D Wilson1,3, F Jichi4, A Merwick1, F Bolsover5, H R Jager6, L Cipolotti7, C Wheeler-Kingshott8, D Hughes9, E Murphy5, R Lachmann5, D J Werring1.   

Abstract

INTRODUCTION: Fabry disease (FD) is an X-linked lysosomal storage disorder resulting in vascular glycosphingolipid accumulation and increased stroke risk. MRI findings associated with FD include white matter hyperintensities (WMH) and cerebral microbleeds (CMBs), suggesting the presence of cerebral small vessel disease. MRI-visible perivascular spaces (PVS) are another promising marker of small vessel disease associated with impaired interstitial fluid drainage. We investigated the association of PVS severity and anatomical distribution with FD. PATIENTS AND METHODS: We compared patients with genetically proven FD to healthy controls. PVS, WMH, lacunes and CMBs were rated on standardised sequences using validated criteria and scales, blinded to diagnosis. A trained observer (using a validated rating scale), quantified the total severity of PVS. We used logistic regression to investigate the association of severe PVS with FD.
RESULTS: We included 33 FD patients (median age 44, 44.1% male) and 20 healthy controls (median age 33.5, 50% male). Adjusting for age and sex, FD was associated with more severe basal ganglia PVS (odds ratio (OR) 5.80, 95% CI 1.03-32.7) and higher total PVS score (OR 4.03, 95% CI 1.36-11.89). Compared with controls, participants with FD had: higher WMH volume (median 495.03 mm3 vs 0, p = 0.0008), more CMBs (21.21% vs none, p = 0.04), and a higher prevalence of lacunes (21.21% vs. 5%, p = 0.23).
CONCLUSIONS: PVS scores are more severe in FD than control subjects. Our findings have potential relevance for FD diagnosis and suggest that impaired interstitial fluid drainage might be a mechanism of white matter injury in FD.

Entities:  

Keywords:  Fabry disease; Magnetic resonance imaging; Neurovascular disease; Perivascular spaces

Mesh:

Substances:

Year:  2020        PMID: 33078310      PMCID: PMC7914182          DOI: 10.1007/s00415-020-10209-7

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  23 in total

1.  Fabry International Prognostic Index: a predictive severity score for Anderson-Fabry disease.

Authors:  Derralynn A Hughes; Mia Malmenäs; Patrick B Deegan; Perry M Elliott; Lionel Ginsberg; Daniel Hajioff; Alex S Ioannidis; Catherine H Orteu; Uma Ramaswami; Michael West; Gregory M Pastores; Crispin Jenkinson
Journal:  J Med Genet       Date:  2012-02-07       Impact factor: 6.318

2.  The Microbleed Anatomical Rating Scale (MARS): reliability of a tool to map brain microbleeds.

Authors:  S M Gregoire; U J Chaudhary; M M Brown; T A Yousry; C Kallis; H R Jäger; D J Werring
Journal:  Neurology       Date:  2009-11-24       Impact factor: 9.910

Review 3.  Cerebrovascular involvement in Fabry disease: current status of knowledge.

Authors:  Edwin Kolodny; Andreas Fellgiebel; Max J Hilz; Katherine Sims; Paul Caruso; Thanh G Phan; Juan Politei; Renzo Manara; Alessandro Burlina
Journal:  Stroke       Date:  2014-12-09       Impact factor: 7.914

Review 4.  Brain and spinal MR imaging findings in mucopolysaccharidoses: a review.

Authors:  D I Zafeiriou; S P Batzios
Journal:  AJNR Am J Neuroradiol       Date:  2012-07-12       Impact factor: 3.825

5.  Basal ganglia enlarged perivascular spaces are linked to cognitive function in patients with cerebral small vessel disease.

Authors:  Marjolein Huijts; Annelien Duits; Julie Staals; Abraham A Kroon; Peter W de Leeuw; Robert J van Oostenbrugge
Journal:  Curr Neurovasc Res       Date:  2014-05       Impact factor: 1.990

6.  White matter perivascular spaces are related to cortical superficial siderosis in cerebral amyloid angiopathy.

Authors:  Andreas Charidimou; Rolf H Jäger; Andre Peeters; Yves Vandermeeren; Patrice Laloux; Jean-Claude Baron; David J Werring
Journal:  Stroke       Date:  2014-08-12       Impact factor: 7.914

7.  Characteristics of Cerebral Microbleeds in Patients with Fabry Disease.

Authors:  Yu Kono; Taichi Wakabayashi; Masahisa Kobayashi; Toya Ohashi; Yoshikatsu Eto; Hiroyuki Ida; Yasuyuki Iguchi
Journal:  J Stroke Cerebrovasc Dis       Date:  2016-03-14       Impact factor: 2.136

8.  Implications of the discovery of brain lymphatic pathways.

Authors:  Jeffrey J Iliff; Steven A Goldman; Maiken Nedergaard
Journal:  Lancet Neurol       Date:  2015-10       Impact factor: 44.182

Review 9.  The Glymphatic System in Central Nervous System Health and Disease: Past, Present, and Future.

Authors:  Benjamin A Plog; Maiken Nedergaard
Journal:  Annu Rev Pathol       Date:  2018-01-24       Impact factor: 23.472

10.  Potential surrogate markers of cerebral microvascular angiopathy in asymptomatic subjects at risk of stroke.

Authors:  Johann Selvarajah; Marietta Scott; Stavros Stivaros; Sharon Hulme; Rachel Georgiou; Nancy Rothwell; Pippa Tyrrell; Alan Jackson
Journal:  Eur Radiol       Date:  2008-11-06       Impact factor: 5.315

View more
  2 in total

1.  Characteristics of Neurological Symptoms in Adult Japanese Patients with Fabry Disease.

Authors:  Jun Sawada; Naoki Nakagawa; Kohei Kano; Tsukasa Saito; Takayuki Katayama; Takaaki Sawada; Ken Momosaki; Kimitoshi Nakamura; Naoyuki Hasebe
Journal:  Intern Med       Date:  2021-01-15       Impact factor: 1.271

2.  Enlarged perivascular spaces and white matter hyperintensities in patients with frontotemporal lobar degeneration syndromes.

Authors:  Ming-Liang Wang; Zheng Sun; Wen-Bin Li; Qiao-Qiao Zou; Peng-Yang Li; Xue Wu; Yue-Hua Li
Journal:  Front Aging Neurosci       Date:  2022-07-28       Impact factor: 5.702

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.